Market icon

Measles cases in U.S. by April 30?

Market icon

Measles cases in U.S. by April 30?

Apr 30

Dec 31

Apr 30

Dec 31

Polymarket

$66,415 Vol.

Polymarket

$66,415 Vol.

1800

$13,899 Vol.

93%

1900

$19,366 Vol.

72%

2000

$22,832 Vol.

41%

2100

$1,515 Vol.

13%

2200

$8,803 Vol.

10%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of March 26, 2026, the Centers for Disease Control and Prevention (CDC) confirms 1,575 measles cases in the U.S. this year across 32 jurisdictions, with 94% outbreak-associated amid 16 active outbreaks—largest in South Carolina (668 cases), Utah (310), Texas (170), and Florida (143). This rapid escalation, surpassing early-year totals from prior outbreaks, stems from declining MMR vaccination coverage (92.5% among kindergartners) and international importations fueling transmission in under-vaccinated communities, where 92% of cases occurred in unvaccinated or unknown-status individuals. Hospitalizations affect 5% of cases, with no deaths reported. Traders should watch weekly CDC surveillance updates and state reports through April 30, as containment efforts and epidemiological shifts could alter trajectories.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$66,415
End Date
Apr 30, 2026
Market Opened
Mar 27, 2026, 1:49 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of March 26, 2026, the Centers for Disease Control and Prevention (CDC) confirms 1,575 measles cases in the U.S. this year across 32 jurisdictions, with 94% outbreak-associated amid 16 active outbreaks—largest in South Carolina (668 cases), Utah (310), Texas (170), and Florida (143). This rapid escalation, surpassing early-year totals from prior outbreaks, stems from declining MMR vaccination coverage (92.5% among kindergartners) and international importations fueling transmission in under-vaccinated communities, where 92% of cases occurred in unvaccinated or unknown-status individuals. Hospitalizations affect 5% of cases, with no deaths reported. Traders should watch weekly CDC surveillance updates and state reports through April 30, as containment efforts and epidemiological shifts could alter trajectories.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$66,415
End Date
Apr 30, 2026
Market Opened
Mar 27, 2026, 1:49 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Related

Market icon

New COVID variant of concern before 2027?

14%
Market icon

Will the 2026 Midterm Elections happen as scheduled?

91%
Market icon

US recession by end of 2026?

31%

Beware of external links.

Frequently Asked Questions

"Measles cases in U.S. by April 30?" is a prediction market on Polymarket with 5 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "1800" at 93%, followed by "1900" at 72%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 93¢ implies that the market collectively assigns a 93% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Measles cases in U.S. by April 30?" has generated $66.4K in total trading volume since the market launched on Mar 24, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Measles cases in U.S. by April 30?," browse the 5 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Measles cases in U.S. by April 30?" is "1800" at 93%, meaning the market assigns a 93% chance to that outcome. The next closest outcome is "1900" at 72%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Measles cases in U.S. by April 30?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.